id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-D-0482-0001,FDA,FDA-2010-D-0482,Draft Guidance for Industry and Investigators: Safety Reporting Requirements for Investigational New Drug Applications andBioavailability/Bioequivalence Studies; Availability,Notice,GDL-Guidance,2010-09-29T04:00:00Z,2010,9,2010-09-29T04:00:00Z,2010-12-29T04:59:59Z,2010-09-29T15:28:33Z,2010-24295,0,0,0900006480b63098